Although GM-CSF administration has shown a reduction in neutrophil apoptosis, which presents as a possible SLE treatment option, further research and sophisticated studies are required to understand its role in the underlying autoimmune diseases. The gene discussed is CSF2; the disease is systemic lupus erythematosus.